FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13755511000001103: Volibris 5mg tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48994501000001115 Volibris 5mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58188901000001112 Volibris 5mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Volibris 5mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Is a Product containing precisely ambrisentan 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has active ingredient Ambrisentan false Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Is a Volibris true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has specific active ingredient Ambrisentan true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Volibris 5mg tablets (GlaxoSmithKline) 30 tablet 3 x 10 tablets Is pack of False Volibris 5mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Volibris 5mg tablets (GlaxoSmithKline) 30 tablet 3 x 10 tablets Has AMP True Volibris 5mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start